These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8037710)

  • 1. TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53.
    Germani A; Fusco C; Martinotti S; Musarò A; Molinaro M; Zani BM
    Biochem Biophys Res Commun; 1994 Jul; 202(1):17-24. PubMed ID: 8037710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation.
    Pocard M; Chevillard S; Villaudy J; Poupon MF; Dutrillaux B; Remvikos Y
    Oncogene; 1996 Feb; 12(4):875-82. PubMed ID: 8632910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 mutational status and survival of human breast cancer MCF-7 cell variants after exposure to X rays or fission neutrons.
    Balcer-Kubiczek EK; Yin J; Lin K; Harrison GH; Abraham JM; Meltzer SJ
    Radiat Res; 1995 Jun; 142(3):256-62. PubMed ID: 7761574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4).
    Pappas IS; Sophianos D; Tzartos S; Tsiftsoglou AS
    Cell Growth Differ; 1996 Jun; 7(6):797-809. PubMed ID: 8780893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein.
    Weinberg WC; Azzoli CG; Chapman K; Levine AJ; Yuspa SH
    Oncogene; 1995 Jun; 10(12):2271-9. PubMed ID: 7784075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development.
    Jerry DJ; Ozbun MA; Kittrell FS; Lane DP; Medina D; Butel JS
    Cancer Res; 1993 Jul; 53(14):3374-81. PubMed ID: 8324748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-P53/K562 from apoptosis.
    Magnelli L; Cinelli M; Chiarugi V
    Biochem Biophys Res Commun; 1995 Oct; 215(2):641-5. PubMed ID: 7488003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
    Isaka K; Fujito A; Sagawa Y; Yudate T; Nishi H; Ito H; Takayama M
    Oncol Rep; 2002; 9(6):1299-305. PubMed ID: 12375038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis in breast cancer cells by TPA.
    Li Y; Bhuiyan M; Mohammad RM; Sarkar FH
    Oncogene; 1998 Dec; 17(22):2915-20. PubMed ID: 9879997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human tumour suppressor gene p53 is alternatively spliced in normal cells.
    Flaman JM; Waridel F; Estreicher A; Vannier A; Limacher JM; Gilbert D; Iggo R; Frebourg T
    Oncogene; 1996 Feb; 12(4):813-8. PubMed ID: 8632903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell line.
    Aguanno S; Bouchè M; Adamo S; Molinaro M
    Cancer Res; 1990 Jun; 50(11):3377-82. PubMed ID: 2159381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells.
    David-Pfeuty T; Chakrani F; Ory K; Nouvian-Dooghe Y
    Cell Growth Differ; 1996 Sep; 7(9):1211-25. PubMed ID: 8877102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein.
    Keleti J; Quezado MM; Abaza MM; Raffeld M; Tsokos M
    Am J Pathol; 1996 Jul; 149(1):143-51. PubMed ID: 8686737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A
    Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells.
    Yen A; Varvayanis S; Platko JD
    Cancer Res; 1993 Jul; 53(13):3085-91. PubMed ID: 8363661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.